A simultaneous remote management and education program increased the rate of heart failure patients achieving full guideline-directed medical therapy at 3 months versus education alone (32.0% vs. 0%).
Does a remote pharmacist-led, navigator-assisted program improve the proportion of patients receiving full guideline-directed medical therapy in adults with heart failure?
A remote pharmacist-led, navigator-assisted program significantly improved the rapid implementation of guideline-directed medical therapy in heart failure patients compared to education alone.
Absolute Event Rate: 32% vs 0%
p-value: p=<0.001
Suboptimal implementation of guideline-directed medical therapy (GDMT) remains a major problem in heart failure (HF) care. The Cooperative Program for Implementation of Optimal Therapy in Heart Failure (COPILOT-HF) trial evaluated an innovative remote strategy to optimize GDMT across the spectrum of HF, irrespective of left ventricular ejection fraction (LVEF). This pragmatic randomized study compared a pharmacist-led, navigator-assisted remote program against traditional provider notification and education. The results, recently presented at the American Heart Association 2025 Scientific Sessions, offer compelling insights into overcoming clinical inertia and improving HF management in the digital age. This mini review examines the trial’s key findings and their potential to reshape HF care delivery.
Rolland et al. (Sat,) conducted a review in Heart failure (n=503). Simultaneous remote GDMT optimization and education vs. Education-first strategy was evaluated on Proportion of participants receiving full GDMT at 3 months (p=<0.001). A simultaneous remote management and education program increased the rate of heart failure patients achieving full guideline-directed medical therapy at 3 months versus education alone (32.0% vs. 0%).